The application discloses a method of immunization against Neisseria meningitidis infection, which includes stages a) immunization of a human patient at the first age from 0 to 1 month with a conjugate vaccine based on bacterial saccharide containing at least one, two or three bacterial saccharides separately conjugated to protein -carrier with the formation of at least one, two or three bacterial saccharide conjugates； and b) immunization of a second-age human patient from 12 to 24 months with Neisseria meningitidis conjugate vaccine containing at least two capsular saccharides selected from the group consisting of serogroup A capsular saccharide N., capsular saccharide N. meningitidis serogroup C (MenC), capsular saccharide N. meningitidis serogroup W135 (MenW135) and capsular saccharide N. meningitidis serogroup Y (MenY), separately conjugated to a carrier protein, where the conjugate vaccine against Neisseria meningitididis is patterned for use with carrier protein, where the conjugate vaccine against Neisseria meningitidis is conjugated with a carrier protein, where the conjugate vaccine against Neisseria meningitidis is conjugated with carrier protein, where the conjugate vaccine against Neisseria meningitidis is conjugated with carrier protein, where the conjugate vaccine against Neisseria meningitidis is coded with carrier protein, the conjugate vaccine against Neisseria meningitidis is patterned with carrier protein. an atoxin and tetanus toxoid.В заявке раскрыт способ иммунизации против инфекции Neisseria meningitidis, включающий стадии а) иммунизации пациента-человека в первом возрасте от 0 до 1 месяца конъюгатной вакциной на основе бактериального сахарида, содержащей по меньшей мере один, два или три бактериальных сахарида, по отдельности конъюгированных с белком-носителем с образованием по меньшей мере одного, двух или трех конъюгатов бактериальных сахаридов； и б) иммунизации пациента-человека во втором возрасте от 12 до 24 месяцев конъюгатной вакциной
